Close

Nivalis Therapeutics to Present at Two Upcoming Investor Conferences

November 2, 2016 4:07 PM EDT

BOULDER, Colo., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Nivalis Therapeutics, Inc. (NASDAQ: NVLS), a clinical stage pharmaceutical company focused on treating people with cystic fibrosis (CF), today announced that Chief Executive Officer, Jon Congleton will present a corporate overview at the 25th Annual Credit Suisse Healthcare Conference and the Stifel 2016 Healthcare Conference.

Details of the two presentations are as follows:

25th Annual Credit Suisse Healthcare Conference Date: Tuesday, November 8th Location: The Phoenician, ArizonaPresentation Time: 4:00 PM MST

Stifel 2016 Healthcare Conference Date: Tuesday, November 15th  Location: The Lotte New York Palace Hotel, New YorkPresentation Time: 10:15 AM EST

Individuals may access a live webcast of the conference presentations on the Nivalis website at www.nivalis.com under "IR Calendar" in the "News / Events" section.  A replay of the webcast will be available on this site for 90 days following the live event.

About Nivalis Therapeutics, Inc.

Nivalis Therapeutics, Inc. (http://www.nivalis.com) is a clinical stage pharmaceutical company committed to the discovery, development and commercialization of therapeutics for people with CF. In addition to developing innovative solutions intended to extend and improve the lives of people with CF, Nivalis plans to utilize its proprietary S-nitrosoglutathione reductase (GSNOR) inhibitor portfolio to develop therapeutics for other diseases.

Contacts:

Investor Relations
John Graziano
1-646-378-2942
[email protected]

Media Relations
Lindsay Rocco
1-862-596-1304
[email protected]

Source: Nivalis Therapeutics, Inc.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases

Related Entities

Credit Suisse, Stifel